A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis
Latest Reports Latest News
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register Today
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 34
Company Profiles
Latest Industry News & Trends
12/10/2019
Dry EyeOphthalmicPress Release
Aurinia Applies Pressure in Race to Market Next Dry Eye Pharmaceutical Drug in US
Aurinia Pharmaceuticals’ initiation of its Phase II/III AUDREY trial in dry eye keeps Aurinia in the middle of the pack of companies racing to develop the next pharmaceutical treatment for dry eye ...
12/13/2019
BreakingCataractOphthalmicRefractiveSurgical
Frinzi Retires from J&J Vision’s Surgical Division; Faust Assumes Role
Johnson and Johnson Vision announced Dec. 4 that industry veteran Tom Frinzi was retiring from his role as worldwide president of surgical vision. Warren Faust officially stepped into the role Dec....
12/13/2019
AcquisitionsBreakingCataractOphthalmicSurgical
BVI Buys Arcadophta, Specialist in Vitreoretinal Surgery Oils and Gases
Beaver-Visitec International (BVI), of Waltham, Massachusetts, announced Dec. 6 that it had acquired Arcadophta—also known as Arcad, an ophthalmic company specializing in silicon oils, gases, and p...
12/13/2019
BreakingClinical TrialGene TherapyOphthalmicRetina
Patient in France Granted Temporary Authorization for GenSight’s LHON Gene Therapy
The National Eye Hospital in Paris and French company GenSight Biologics announced Dec. 9 that that the French Competent Authority granted a patient Temporary Authorization for Use for Lumevoq, Gen...
12/13/2019
BreakingOphthalmicPharmaRetina
Regeneron’s Eylea Injection Prefilled Syringe Now Available
Regeneron, of Tarrytown, New York, has announced that the Eylea (aflibercept) prefilled syringe is now available for doctors to order. The 2 mg, single-dose, sterilized prefilled syringe requires f...
12/13/2019
BreakingDry EyeFundingOphthalmicPharma
Aurinia Raises $191.7 Million in Public Offering of Stock
Aurinia Pharmaceuticals, focused on advancing voclosporin in multiple indications, including dry eye, announced Dec. 12 that it had raised $191.7 million, before expenses, in an underwritten public...
12/13/2019
BreakingFundingGene TherapyOphthalmicRetina
Limelight Bio Secures $75 Million to Develop Next Generation Gene Therapies
Limelight Bio announced Dec. 5 that it had raised $75 million in new financing funded by Apple Tree Partners (ATP), a leading life sciences innovation fund. Limelight Bio, with operations in Philad...
12/13/2019
BreakingCataractFundingOphthalmic
Omeros Raises $57.5 Million in Sale of Shares, Exercise of Option
Omeros announced Dec. 13 the full exercise and closing of the sale of 572,518 shares of common stock to the underwriter of its previously announced public offering. When combined with shares sold i...
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.